Its no secret that perimenopause and menopause can be tough life stages in so many ways, with a body that feels and looks different than it used to
My assumption is that, within the next 12-18 months, we will get something from [big] pharma and the FDA stating that a select amount [of peptides] will most likely be deemed Class 1 [from their current Class 2], which will mean that theyre legal to compound [in the U.S
Also known as copper tripeptide-3
Peri-lesional injection requires precise anatomical knowledge and a higher technical skill level, and the marginal benefit over subcutaneous delivery is not clearly established
In other words, BPC-157 is considered an experimental peptide and is legally available only for scientific research, similar to IGF-1 LR3
Its also known for brightening skin and boosting immunity from the inside out